Global and U.S. Homecare Ventilator Market Report, Published by QY Research.

QY Research has released a comprehensive new market report on Homecare Ventilator, a medical device that assists or takes over a person's breathing outside of a hospital setting. Designed for long‐term respiratory support, these ventilators are used by people with chronic respiratory conditions such as COPD, neuromuscular disease, spinal injuries, or sleep‐related breathing disorders. Homecare ventilators are typically portable, quieter, and easier to operate than ICU ventilators.

Core Market Data

Global market size: USD 2679 million
CAGR (2024-2030): 11.1%
Average price: USD 2400 per unit
Annual production: 1 million units
Gross margin: 55%
Production capacity: 1.3 million units

List of Main Players

Philips - Public (Euronext: PHIA, Netherlands)
ResMed - Public (NYSE: RMD, USA)
Fisher & Paykel - Public (NZX: FPH, New Zealand)
Medtronic - Public (NYSE: MDT, Ireland)
GE Healthcare - Public (NYSE: GE, USA)
Becton Dickinson - Public (NYSE: BDX, USA)
Drägerwerk - Public (ETR: DRW3, Germany)
Mindray Bio-Medical - Public (SZSE: 300760, China)
Yuwell Medical Equipment - Public (SZSE: 002223, China)
Löwenstein Medical - Private (Germany)
Hamilton Medical - Private (Switzerland)
Vyaire Medical - Private (USA)
Resvent Medical - Private (China)
Inovytec Medical - Private (Israel)
Kare Medical - Private (Turkey)
Hunan VentMed Medical - Private (China)
Siriusmed Medical - Private (China)

1. By Product Type

Invasive (via tracheostomy)
Non-invasive (via mask or nasal interface)

2. by Portability / Power Source

Stationary Home Units
Portable Ventilators
Transport / Emergency Ventilators

3. By Controlled Mode

Volume-Controlled Ventilators
Pressure-Controlled Ventilators
Adaptive / Hybrid Ventilators

4. By Application

Home Healthcare Services
Respiratory Therapy Centers
Rehabilitation Centers
Telemedicine and Remote Patient Monitoring
Palliative care Facilities
Others

Case Study for Bidding

Time: Q2 2025
Supplier: ResMed Inc. (NYSE: RMD, USA)
Buyer: Sunrise Homecare Solutions Ltd., China
Product: ResMed Stellar 150 Homecare Ventilators (Non-Invasive, Adaptive/Hybrid)
Quantity: 250 units
Contract Value: USD 1,125,000
Delivery Timeline: 8 weeks

Case Study for End Using

End User: A chronic COPD patient

Application: The patient requires long-term non-invasive ventilatory support at home to manage chronic obstructive pulmonary disease (COPD). The ResMed Stellar 150 Homecare Ventilator was installed to provide adaptive pressure support, improve oxygenation, reduce nighttime hypoventilation, and enhance daily activity tolerance. The device also features remote monitoring, allowing his respiratory therapist to track performance and adjust settings as needed, ensuring safe, continuous care at home.

Installation Location / Usage Stage

Installation Location: The homecare ventilator was installed in the patient's bedroom, near a power source and Wi-Fi to enable remote monitoring. The setup ensures quiet operation, patient comfort, and safe access for caregivers.
Usage Stage: The ventilator is used for long-term respiratory support, primarily during nighttime for sleep-disordered breathing and intermittently during the day as needed. Remote monitoring allows the respiratory therapist to adjust settings, ensuring continuous, effective homecare.

Purpose

Support Breathing: Assist patients with chronic respiratory conditions or neuromuscular disorders in maintaining adequate ventilation.
Improve Quality of Life: Reduce fatigue, prevent hypoxemia, and enable patients to remain at home safely.
Enable Remote Monitoring: Allow healthcare providers to track respiratory parameters and adjust therapy without frequent hospital visits.

Effect

Enhanced Respiratory Function: Improved oxygenation and reduced episodes of shortness of breath.
Better Sleep and Daily Activity: Patients experience fewer nighttime breathing issues, leading to more restful sleep and higher daytime energy.
Reduced Hospital Visits: Continuous homecare and remote monitoring lower the risk of complications, decreasing the need for emergency or inpatient care.

Alternative Technologies

Oxygen Concentrators: Provide supplemental oxygen but do not assist with ventilation or CO2 removal.
CPAP/BiPAP Machines: Non-invasive devices for sleep-disordered breathing, but less suitable for patients needing full ventilatory support.
Hospital/ICU Ventilators: Highly capable but bulky, expensive, and not designed for long-term home use.

Therefore, Homecare Ventilator remain a highly efficient tool for providing long-term respiratory support, improving patient quality of life, reducing hospital visits, and enabling continuous, remotely monitored care. They help patients maintain independence at home while ensuring safety, early detection of complications, and optimized therapy for chronic respiratory conditions. By combining portability, adaptive ventilation modes, and telehealth integration, these devices offer an effective and practical solution for managing complex respiratory needs outside the hospital setting.

About QY Research

QY Research has established close partnerships with over 71,000 global leading players. With more than 20,000 industry experts worldwide, we maintain a strong global network to efficiently gather insights and raw data.

Our 36-step verification system ensures the reliability and quality of our data. With over 2 million reports, we have become the world's largest market report vendor. Our global database spans more than 2,000 sources and covers data from most countries, including import and export details.

We have partners in over 160 countries, providing comprehensive coverage of both sales and research networks. A 90% client return rate and long-term cooperation with key partners demonstrate the high level of service and quality QY Research delivers.

More than 30 IPOs and over 5,000 global media outlets and major corporations have used our data, solidifying QY Research as a global leader in data supply. We are committed to delivering services that exceed both client and societal expectations.

For Inquiries:

USA: +1-626-295-2442

Canada: +1-778-907-6631

China: +86-150-1303-8387

Japan: +81-90-3800-9273

South Korea: +82-2883-1278

India: +91-866-9986-909

Indonesia: +62-818-510-991

Germany: +49-15788468916

Switzerland: +41-765899438

Portugal: +351-910983247

Email: global@qyresearch.com

www.qyresearch.com

This release was published on openPR.